Literature DB >> 21620679

Long-term clinical outcomes after deferral of percutaneous coronary intervention of intermediate coronary stenoses based on coronary pressure-derived fractional flow reserve.

Tomofumi Misaka1, Hiroyuki Kunii, Hiroyuki Mizukami, Nobuo Sakamoto, Kazuhiko Nakazato, Yasuchika Takeishi.   

Abstract

Coronary pressure-derived fractional flow reserve (FFR) has been used to evaluate functional severity of coronary artery stenoses. The cut-off point of 0.75 was considered to be the indication for percutaneous coronary intervention (PCI). In this study, we examined the prognosis of patients in whom PCI was deferred because the lesion was not significant by FFR (≥0.75). We measured FFR of 44 patients (50 lesions with angiographically intermediate stenoses by pressure wire between 2002 and 2009. Out of 44 patients (50 lesions), functionally non-significant stenoses with FFR≥0.75 were 29 patients (33 lesions) and PCI was deferred. In the remaining 15 patients (17 lesions), FFR was <0.75 and PCI was performed. Patients were followed up for an average period of 53 months with endpoints of major adverse cardiac events (MACE; cardiac death, acute coronary syndrome, PCI, and coronary artery bypass grafting). The rate of MACE was 2/29 (6.9%) in patients with FFR≥0.75 and 2/15 (13.3%) in those with FFR<0.75, and it was not statistically different between the two groups. Since long-term clinical outcomes after deferral of PCI of intermediate coronary stenoses based on FFR were excellent (annual event rate 1.6%/year), FFR is a useful index to judge the indication of PCI and risk-stratify patients for MACE.
Copyright © 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21620679     DOI: 10.1016/j.jjcc.2011.03.007

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  5 in total

1.  Value of Delta Fractional Flow Reserve (ΔFFR) For Predicting Coronary Ischemic Lesions.

Authors:  Vahid Eslami; Morteza Safi; Mohammad Hasan Namazi; Mehdi Pishgahi; Amir Eftekharzade; Sayyed Ali Eftekharzadeh
Journal:  Galen Med J       Date:  2020-10-03

2.  Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice.

Authors:  Jing Li; Muhamad Y Elrashidi; Andreas J Flammer; Ryan J Lennon; Malcolm R Bell; David R Holmes; John F Bresnahan; Charanjit S Rihal; Lilach O Lerman; Amir Lerman
Journal:  Eur Heart J       Date:  2013-01-23       Impact factor: 29.983

3.  Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty (FORZA) trial: study protocol for a randomized controlled trial.

Authors:  Francesco Burzotta; Antonio Maria Leone; Giovanni Luigi De Maria; Giampaolo Niccoli; Valentina Coluccia; Giancarlo Pirozzolo; Silvia Saffioti; Cristina Aurigemma; Carlo Trani; Filippo Crea
Journal:  Trials       Date:  2014-04-23       Impact factor: 2.279

Review 4.  Should fraction flow reserve be considered an important decision-making tool to stratify patients with stable coronary artery disease for percutaneous coronary intervention?: A meta-analysis.

Authors:  Pravesh Kumar Bundhun; Chakshu Gupta; Feng Huang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

Review 5.  Invasive physiological indices to determine the functional significance of coronary stenosis.

Authors:  Firas R Al-Obaidi; William F Fearon; Andy S C Yong
Journal:  Int J Cardiol Heart Vasc       Date:  2018-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.